Abstract:Zhipan Teng, Qi Li, &ast Xiao-fei Shen &ast Department of Otorhinolaryngology, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, 210008, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xiao-fei Shen; Qi Li, Department of Otorhinolaryngology, Children's Hospital of Nanjing Medical University, 72 Guangzhou Road, Nanjing, Jiangsu Province, 210008, People's Republic of China, Email ; Objective: Human microbiome is involved in the pathogenesis of allergic diseases, but the impact of nasal microbiota on allergic rhinitis (AR) symptoms severity has not been evaluated. This study aimed to characterize nasal microbiome in AR children and its correlations with AR symptoms. Methods: According to diagnostic guidelines for AR, 45 AR children and 40 healthy subjects were recruited from July to August in 2023. Based on the total score of nasal symptoms (TNSS), the 45 AR patients were divided into a mild AR group (MAR) (n = 16) and a moderate or severe AR group (MSAR) (n = 29). Nasal swabs were collected for microbiome analysis using 16S-rDNA sequencing. Results: The Simpson and Shannon indices were significantly higher in the AR group compared to the health control group, indicating an increase of nasal microbiota at the species evenness level in AR children. Moreover, the species evenness was significantly increased in the MSAR group compared to the MAR group. Staphylococcus (member of the Firmicutes phylum) was significantly dominant in the AR group, but Moraxella (member of the Proteobacteria phylum) was significantly dominant in the CG group. The LEfSe analysis showed that the mean relative abundances of Ralstonia in the MSAR group was higher than that in the MAR group. Meanwhile, the abundance divided by Ralstonia of Spearman correlation coefficients was positively correlated with the TNSS of AR symptoms (r = 0.4, P = 0.009). Conclusion: The elevation of species evenness in nasal microbiome was likely related to the aggravation of AR symptoms. The Ralstonia may play a pro-inflammatory role in AR. Plain Language Summary: In this study, 45 AR children and 40 healthy subjects were recruited and the AR patients were divided into a mild AR group (MAR) (n = 16) and a moderate or severe AR group (MSAR) (n = 29) based on the total score of nasal symptoms (TNSS). High throughput 16S rDNA analysis was employed to evaluate the nasal microbiome in AR children and its correlations with AR symptoms. We found that the Simpson and Shannon indices were significantly higher in the AR group than in the CG group, and in the MSAR group than in the MAR group, indicating that the rise of species evenness in nasal microbiome may be related to the occurrence and aggravation of AR symptoms. Staphylococcu s (member of the Firmicutes phylum) was significantly dominant in the AR group, and the abundance of Ralstonia was positively correlated with the TNSS of AR symptoms. Keywords: nasal microbes, allergic rhinitis, symptoms severity, children Human microbiome was coined in 2001 to describe a collection of commensal, symbiotic, and pathogenic microorganisms living in the human body. 1 New DNA sequencing technologies and data-mining tools have transformed microbiome analyses. 2 High throughput 16S rDNA analysis can be employed to evaluate the overall alpha and beta diversities in microbiome. In recent years, research has rapidly expanded into the role of human microbiome in health and disease pathogenesis. 3 Previous studies have focused on microbiota in the gastrointestinal tract 4 and lower airways (lung) 5 but rarely in the upper airways (nasal and oral passages). The human nasal mucosa harbors abundant microorganisms, including commensal microbes that maintain a symbiotic relationship. 6 Culture-independent 16S-rDNA sequencing revealed that at the phylum level, the nasal microbiota of healthy subjects consists primarily of Actinobacteria, Firmicutes , and Proteobacteri a. 7,8 At the genus level, the most prevalent are Moraxella, Haemophilus, Streptococcus , and Flavobacterium . 9 Knowledge about microbiota dysbiosis in the allergic nasal mucosa may help explain an individual's susceptibility to allergens and allergic inflammation. 10 Allergic rhinitis (AR), an immunoglobulin E (IgE) and T helper (Th)2-mediated inflammatory nasal disease, is caused by sensitized immune responses to inhaled allergens, such as pollens, environmental fungi, dust mites, bacteria, and animal dander. 11 Accumulating -Abstract Truncated-

Exacerbation of allergic rhinitis by the commensal bacterium Streptococcus salivarius

Microbial characterization of the nasal cavity in patients with allergic rhinitis and non-allergic rhinitis

Neuroimmune communication in allergic rhinitis

Dysbiosis of Fecal Microbiota in Allergic Rhinitis Patients

Airway Microbiome and Serum Metabolomics Analysis Identify Differential Candidate Biomarkers in Allergic Rhinitis

Comparing the Nasal Bacterial Microbiome Diversity of Allergic Rhinitis, Chronic Rhinosinusitis and Control Subjects

Correlations of Nasal Microbiome with Allergic Rhinitis and Its Symptoms Severity in Children Progression

Fecal and serum metabolomic signatures and gut microbiota characteristics of allergic rhinitis mice model

The aberrant tonsillar microbiota modulates autoimmune responses in rheumatoid arthritis

Intra-genus dysbiosis of Streptococcus in tonsillar microbiota is associated with host immune features in rheumatoid arthritis

The Salivary Microbiota, Cytokines, and Metabolome in Patients with Ankylosing Spondylitis Are Altered and More Proinflammatory Than Those in Healthy Controls

Altered expression of IL-18, IL-18 binding protein and IL-18 receptor in blood monocytes of patients with allergic rhinitis

The oral bacteriomes of patients with allergic rhinitis and asthma differ from that of healthy controls

Gut microbial characteristics of adult patients with allergy rhinitis

Hydrogen inhalation: A novel approach to alleviating allergic rhinitis symptoms by modulating nasal flora

Rare Constituents of the Nasal Microbiome Contribute to the Acute Exacerbation of Chronic Rhinosinusitis

Staphylococcus aureus Phenol-Soluble Modulins Mediate Interspecies Competition with Upper Respiratory Commensal Bacteria

Co-infection of Malassezia sympodialis With Bacterial Pathobionts Pseudomonas aeruginosa or Staphylococcus aureus Leads to Distinct Sinonasal Inflammatory Responses in a Murine Acute Sinusitis Model

Nasal Bacterial Microbiome Differs Between Healthy Controls and Those With Asthma and Allergic Rhinitis

Exploring the Role of Indoor Microbiome and Environmental Characteristics in Rhinitis Symptoms among University Students

The nasal microbiome in patients suffering from non-steroidal anti-inflammatory drugs-exacerbated respiratory disease in absence of corticosteroids